BNT3212

· BioNTech SE

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BNT3212, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid Tumors [Phase 1, Phase 2]

See pricing